Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 1
1986 2
1989 2
1992 1
1993 1
1994 1
1995 2
1996 1
1997 1
1998 2
1999 1
2000 1
2002 1
2003 2
2006 2
2007 1
2008 1
2009 3
2010 5
2011 2
2012 5
2013 5
2014 3
2015 3
2016 2
2017 6
2018 9
2019 8
2020 3
2021 3
2022 3
2023 8
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Response to "NGS, the New Global Standard?".
Ou SI, Hong JL, Christopoulos P, Lin HM, Vincent S, Churchill EN, Soeda J, Kazdal D, Thomas M, Stenzinger A. Ou SI, et al. Among authors: hong jl. J Thorac Oncol. 2023 Oct;18(10):e116-e118. doi: 10.1016/j.jtho.2023.07.022. J Thorac Oncol. 2023. PMID: 37758351 Free article. No abstract available.
Distribution and Detectability of EGFR Exon 20 Insertion Variants in NSCLC.
Ou SI, Hong JL, Christopoulos P, Lin HM, Vincent S, Churchill EN, Soeda J, Kazdal D, Stenzinger A, Thomas M. Ou SI, et al. Among authors: hong jl. J Thorac Oncol. 2023 Jun;18(6):744-754. doi: 10.1016/j.jtho.2023.01.086. Epub 2023 Feb 3. J Thorac Oncol. 2023. PMID: 36738930 Free article.
Efficacy of Mobocertinib and Amivantamab in Patients With Advanced Non-Small Cell Lung Cancer With EGFR Exon 20 Insertions Previously Treated With Platinum-Based Chemotherapy: An Indirect Treatment Comparison.
Ou SI, Prawitz T, Lin HM, Hong JL, Tan M, Proskorovsky I, Hernandez L, Jin S, Zhang P, Lin J, Patel J, Nguyen D, Neal JW. Ou SI, et al. Among authors: hong jl. Clin Lung Cancer. 2024 May;25(3):e145-e152.e3. doi: 10.1016/j.cllc.2023.11.011. Epub 2023 Dec 4. Clin Lung Cancer. 2024. PMID: 38114357 Clinical Trial.
The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions.
Christopoulos P, Kluck K, Kirchner M, Lüders H, Roeper J, Falkenstern-Ge RF, Szewczyk M, Sticht F, Saalfeld FC, Wesseler C, Hackanson B, Dintner S, Faehling M, Kuon J, Janning M, Kauffmann-Guerrero D, Kazdal D, Kurz S, Eichhorn F, Bozorgmehr F, Shah R, Tufman A, Wermke M, Loges S, Brueckl WM, Schulz C, Misch D, Frost N, Kollmeier J, Reck M, Griesinger F, Grohé C, Hong JL, Lin HM, Budczies J, Stenzinger A, Thomas M. Christopoulos P, et al. Among authors: hong jl. Eur J Cancer. 2022 Jul;170:106-118. doi: 10.1016/j.ejca.2022.04.020. Epub 2022 May 20. Eur J Cancer. 2022. PMID: 35598358
Acid-sensing by airway afferent nerves.
Lee LY, Gu Q, Xu F, Hong JL. Lee LY, et al. Among authors: hong jl. Pulm Pharmacol Ther. 2013 Oct;26(5):491-7. doi: 10.1016/j.pupt.2013.03.010. Epub 2013 Mar 21. Pulm Pharmacol Ther. 2013. PMID: 23524016 Free PMC article.
85 results